Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA061253-04
Application #
2101986
Study Section
Special Emphasis Panel (SRC (56))
Project Start
1993-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Lamb, Justin; Ramaswamy, Sridhar; Ford, Heide L et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-34
Fournier, Marcia V; Martin, Katherine J; Graner, Edgard et al. (2003) Sensitive assays for detection of lung cancer. Molecular markers in blood samples. Methods Mol Med 75:239-50
Sotiropoulou, Georgia; Kono, Mari; Anisowicz, Anthony et al. (2002) Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer. Mol Med 8:42-55
Biswas, D K; Cruz, A; Pettit, N et al. (2001) A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Mol Med 7:59-67
Martin, K J; Graner, E; Li, Y et al. (2001) High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A 98:2646-51
Fournier, M V; Martin, K J; Pardee, A B (2001) Solid tumor cancer markers and applications to steroid hormone research. Methods Mol Biol 176:329-40
Li, Y; Li, C J; Yu, D et al. (2000) Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells. Mol Med 6:1008-15
Bosch, I; Melichar, H; Pardee, A B (2000) Identification of differentially expressed genes from limited amounts of RNA. Nucleic Acids Res 28:E27
Guan, R J; Ford, H L; Fu, Y et al. (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749-55
Huang, L; Pardee, A B (2000) Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med 6:849-66

Showing the most recent 10 out of 35 publications